ALK and neoplasm: Further, using single-cell RNA sequencing, Maynard et al. recently revealed the EML4-ALK-positive tumor sample from the patient after multiple lines of ALK-TKI and other therapy contained KRAS G12C and KRAS G13D mutations38.